Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gene G Olinger

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Plos One|March 23, 2018
Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugsElena Postnikova, Yu Cong, Lisa Evans DeWald, et al.
Cell Reports|September 15, 2015
Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody CocktailJeffrey R Kugelman, Johanny Kugelman-Tonos, Jason T Ladner, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2021
Inhibition of Arenaviruses by Combinations of Orally Available Approved DrugsShawn Herring, Jessica M Oda, Jessica Wagoner, et al.
Science Translational Medicine|August 23, 2013
Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktailJames Pettitt, Larry Zeitlin, Do H Kim, et al.
The Journal of Biological Chemistry|June 3, 2010
A novel L-ficolin/mannose-binding lectin chimeric molecule with enhanced activity against Ebola virusIan C Michelow, Mingdong Dong, Bruce A Mungall, et al.
Science Translational Medicine|June 5, 2015
A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activityLisa M Johansen, Lisa Evans DeWald, Charles J Shoemaker, et al.
The Journal of Infectious Diseases|July 18, 2018
In Vitro and In Vivo Activity of Amiodarone Against Ebola VirusJulie Dyall, Joshua C Johnson, Brit J Hart, et al.
Plos Neglected Tropical Diseases|July 30, 2019
Inhibition of Ebola Virus by a Molecularly Engineered Banana LectinEvelyn M Covés-Datson, Julie Dyall, Lisa Evans DeWald, et al.
Plos Pathogens|June 27, 2015
Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPsMarnie L Fusco, Takao Hashiguchi, Robyn Cassan, et al.
Plos One|April 11, 2013
Lectin-dependent enhancement of Ebola virus infection via soluble and transmembrane C-type lectin receptorsMatthew Brudner, Marshall Karpel, Calli Lear, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Plos One|March 23, 2018
Testing therapeutics in cell-based assays: Factors that influence the apparent potency of drugsElena Postnikova, Yu Cong, Lisa Evans DeWald, et al.
Cell Reports|September 15, 2015
Emergence of Ebola Virus Escape Variants in Infected Nonhuman Primates Treated with the MB-003 Antibody CocktailJeffrey R Kugelman, Johanny Kugelman-Tonos, Jason T Ladner, et al.
Antimicrobial Agents and Chemotherapy|January 20, 2021
Inhibition of Arenaviruses by Combinations of Orally Available Approved DrugsShawn Herring, Jessica M Oda, Jessica Wagoner, et al.
Science Translational Medicine|August 23, 2013
Therapeutic intervention of Ebola virus infection in rhesus macaques with the MB-003 monoclonal antibody cocktailJames Pettitt, Larry Zeitlin, Do H Kim, et al.
The Journal of Biological Chemistry|June 3, 2010
A novel L-ficolin/mannose-binding lectin chimeric molecule with enhanced activity against Ebola virusIan C Michelow, Mingdong Dong, Bruce A Mungall, et al.
Science Translational Medicine|June 5, 2015
A screen of approved drugs and molecular probes identifies therapeutics with anti-Ebola virus activityLisa M Johansen, Lisa Evans DeWald, Charles J Shoemaker, et al.
The Journal of Infectious Diseases|July 18, 2018
In Vitro and In Vivo Activity of Amiodarone Against Ebola VirusJulie Dyall, Joshua C Johnson, Brit J Hart, et al.
Plos Neglected Tropical Diseases|July 30, 2019
Inhibition of Ebola Virus by a Molecularly Engineered Banana LectinEvelyn M Covés-Datson, Julie Dyall, Lisa Evans DeWald, et al.
Plos Pathogens|June 27, 2015
Protective mAbs and Cross-Reactive mAbs Raised by Immunization with Engineered Marburg Virus GPsMarnie L Fusco, Takao Hashiguchi, Robyn Cassan, et al.
Plos One|April 11, 2013
Lectin-dependent enhancement of Ebola virus infection via soluble and transmembrane C-type lectin receptorsMatthew Brudner, Marshall Karpel, Calli Lear, et al.
Pageof 8